University of California San Francisco ( Site 0023) — San Francisco, California

University of California San Francisco ( Site 0023) is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

University of California San Francisco ( Site 0023) has participated in 2 clinical trials.

Therapeutic areas: Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Francisco ( Site 0023)?

University of California San Francisco ( Site 0023) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Francisco ( Site 0023) conducted?

University of California San Francisco ( Site 0023) has 2 clinical trials on record. Their work covers Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell.

Is University of California San Francisco ( Site 0023) accredited by Crixeo Health?

University of California San Francisco ( Site 0023) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Francisco ( Site 0023)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.